[Rituximab in cold agglutinin disease] (Q73727713)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 August 2003

edit

Language	Label	Description	Also known as
English	[Rituximab in cold agglutinin disease]	scientific article published on 01 August 2003

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12888170

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888170%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 November 2019

title

[Rituximab in cold agglutinin disease] (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12888170

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888170%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 November 2019

main subject

Cold agglutinin disease

1 reference

based on heuristic

inferred from title

rituximab

1 reference

based on heuristic

inferred from title

author name string

F Camou

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12888170

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888170%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 November 2019

J-F Viallard

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12888170

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888170%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 November 2019

J-L Pellegrin

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12888170

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888170%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 November 2019

publication date

1 August 2003

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12888170

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888170%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 November 2019

published in

Revue de Médecine Interne

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12888170

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888170%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 November 2019

volume

24

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12888170

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888170%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 November 2019

issue

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12888170

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888170%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 November 2019

page(s)

501-504

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12888170

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888170%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 November 2019

cites work

Clinical syndromes associated with cold agglutinins

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900139-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of cold agglutination syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900139-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900139-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab: a very efficient therapy in cold agglutinins and refractory autoimmune haemolytic anaemia associated with CD20-positive, low-grade non-Hodgkin's lymphoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900139-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900139-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Monotherapy with rituximab induces rapid remission of recurrent cold agglutinin-mediated hemolytic anemia in a patient with indolent lympho-plasmacytic lymphoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900139-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Severe cold hemagglutinin disease (CHD) successfully treated with rituximab

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900139-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete, long-term remission of refractory idiopathic cold haemagglutinin disease after Mabthera

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900139-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Q59446775

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900139-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Remission of severe cold agglutinin disease after Rituximab therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900139-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effects of rituximab on primary cold agglutinin disease refractory to conventional therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900139-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Mixed warm and cold autoimmune hemolytic anemia: complete recovery after 2 courses of rituximab treatment

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900139-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of primary chronic cold agglutinin disease with rituximab: maintenance therapy may improve the results

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0248-8663%2803%2900139-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0248-8663(03)00139-5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12888170

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888170%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 November 2019

PubMed publication ID

12888170

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12888170

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12888170%20AND%20SRC:MED&resulttype=core&format=json

retrieved

6 November 2019

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73727713&oldid=2234533320"